1. Home
  2. LFCR

as of 02-26-2026 3:54pm EST

$7.36
+$0.03
+0.41%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Founded: 1986 Country:
United States
United States
Employees: N/A City: CHASKA
Market Cap: 269.8M IPO Year: 1996
Target Price: N/A AVG Volume (30 days): 123.7K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.29 EPS Growth: -496.88
52 Week Low/High: $4.76 - $8.98 Next Earning Date: N/A
Revenue: $557,559,000 Revenue Growth: 6.36%
Revenue Growth (this year): 2.8% Revenue Growth (next year): 11.51%
P/E Ratio: -25.28 Index: N/A
Free Cash Flow: -13621000.0 FCF Growth: N/A

AI-Powered LFCR Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 74.07%
74.07%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: